GlassScriptPhysician profile
Abinash Mishra
NPI 1063999183
$3,609.27
in general payments reported to CMS, 2019-2025
20 companies · $675 in 2025
The $675 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $45.48 · 2021: $68.77 · 2022: $1,471 · 2023: $371 · 2024: $631 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,676.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kairos Surgical INC | $1,210.04 | 2022 | |
| Smith+Nephew, INC. | $454.16 | 2021-2025 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Amgen INC. | $398.41 | 2024-2025 | Krystexxa |
| Medtronic, INC. | $232.67 | 2022-2023 | Intellis Adaptivestim |
| Integra Lifesciences Corporation | $222.98 | 2019-2020 | |
| Organogenesis INC. | $196.68 | 2022-2025 | Puraply, Affinity |
| Abbvie INC. | $145.45 | 2024-2025 | |
| Horizon Therapeutics Plc | $142.66 | 2022-2023 | Krystexxa |
| Ani Pharmaceuticals, INC. | $84.52 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $76.95 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Kci USA, INC. | $76.00 | 2019 | |
| Medline Industries LP | $67.10 | 2020-2021 | |
| Averitas Pharma INC. | $57.14 | 2024 | Qutenza |
| Wright Medical Technology, INC. | $46.99 | 2019 | |
| Kerecis Limited | $45.21 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $43.32 | 2024 | Nuzyra |
| Solventum Corporation | $31.55 | 2025 | Activ.A.C. |
| Convatec INC. | $30.59 | 2019 | |
| Ibsa Pharma INC. | $24.74 | 2024 | Tirosint, Licart |
| Djo, LLC | $22.11 | 2025 | Cmf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abinash Mishra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.